Related Experiment Videos

Overexpression of Smad7 results in severe pathological alterations in multiple epithelial tissues

Wei He1, Allen G Li, Dongyan Wang

  • 1Department of Dermatology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.

The EMBO Journal
|May 29, 2002
PubMed

Insights

Smad7 inhibits transforming growth factor beta (TGFbeta) signaling in vivo. Transgenic mice expressing Smad7 showed developmental defects and early death, revealing its critical role in epithelial tissue homeostasis.

Area of Science:

  • Developmental Biology
  • Molecular Biology
  • Cell Signaling

Background:

  • Smad7 is known to inhibit transforming growth factor beta (TGFbeta) signaling biochemically.
  • The in vivo functions of Smad7, particularly during development, remain largely uncharacterized.

Purpose of the Study:

  • To elucidate the in vivo functions of Smad7 during mammalian development.
  • To investigate the role of Smad7 in the homeostasis of epithelial tissues.

Main Methods:

  • Generation of transgenic mice (K5.Smad7) expressing Smad7 under the control of a keratin K5 promoter.
  • Phenotypic analysis of K5.Smad7 mice, including gross pathology, histology, and molecular assessments.

Main Results:

  • K5.Smad7 mice exhibited severe developmental abnormalities, including corneal defects, delayed hair follicle morphogenesis, epidermal hyperproliferation, and thymic atrophy.
  • These mice experienced significant thymocyte death, indicating Smad signaling is crucial for thymocyte survival.
  • Reduced Smad phosphorylation and decreased protein levels of TGFbeta superfamily receptors were observed in affected tissues.

Conclusions:

  • Smad7 acts as a potent in vivo inhibitor of TGFbeta superfamily signal transduction.
  • Smad7 is essential for the proper development and maintenance of homeostasis in multiple epithelial tissues.

Related Concept Videos